Longitudinal study of differential protein expression in an Alzheimer's mouse model lacking inducible nitric oxide synthase

Journal of Proteome Research

Volumn 12, Issue 10, 2013, Pages 4462-4477

  Hoos, Michael D ^a   Richardson, Brenna M ^b   Foster, Matthew W ^b   Everhart, Angela ^a   Thompson, J Will ^b   Moseley, M Arthur ^b   Colton, Carol A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; mass spectrometry; neurodegeneration; NOS2; phosphorylation; proteomics

Indexed keywords

AMYLOID; INDUCIBLE NITRIC OXIDE SYNTHASE; PHOSPHOPEPTIDE; TAU PROTEIN; TITANIUM DIOXIDE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; LIQUID CHROMATOGRAPHY; LONGITUDINAL STUDY; MALE; MOUSE; MOUSE MODEL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TANDEM MASS SPECTROMETRY;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMALS; BRAIN; CHROMATOGRAPHY, ION EXCHANGE; CHROMATOGRAPHY, REVERSE-PHASE; HUMANS; LONGITUDINAL STUDIES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHOPEPTIDES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; RECEPTORS, COMPLEMENT; TANDEM MASS SPECTROMETRY; TAU PROTEINS;

EID: 84885192215     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr4005103     Document Type: Article

References (104)

1. Nagy, Z.; Esiri, M. M.; Joachim, C.; Jobst, K. A.; Morris, J. H.; King, E. M.; Hindley, N. J.; McDonald, B.; Litchfield, S.; Barnetson, L.; Smith, A. D. Comparison of pathological diagnostic criteria for Alzheimer disease Alzheimer Dis. Assoc. Disord. 1998, 12 (3) 182-9
2. Selkoe, D. J. Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 2001, 81 (2) 741-66
3. Rogers, J. The inflammatory response in Alzheimer's disease J. Periodontol. 2008, 79 (8 Suppl) 1535-43
4. Colton, C. A.; Chernyshev, O. N.; Gilbert, D. L.; Vitek, M. P. Microglial contribution to oxidative stress in Alzheimer's disease Ann. N.Y. Acad. Sci. 2000, 899, 292-307
5. Selkoe, D. J. The genetics and molecular pathology of Alzheimer's disease: roles of amyloid and the presenilins Neurol. Clin. 2000, 18 (4) 903-22
6. Gilbert, B. J. The role of amyloid beta in the pathogenesis of Alzheimer's disease J. Clin. Pathol. 2013, 66 (5) 362-6
7. Mullane, K.; Williams, M. Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond? Biochem. Pharmacol. 2013, 85 (3) 289-305
8. Castellani, R. J.; Perry, G. Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress Arch. Med. Res. 2012, 43 (8) 694-8
9. Guo, Q.; Fu, W.; Sopher, B. L.; Miller, M. W.; Ware, C. B.; Martin, G. M.; Mattson, M. P. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice Nat. Med. 1999, 5 (1) 101-6
10. Wang, R.; Dineley, K. T.; Sweatt, J. D.; Zheng, H. Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis Neuroscience 2004, 126 (2) 305-12
11. Lewis, J.; McGowan, E.; Rockwood, J.; Melrose, H.; Nacharaju, P.; Van Slegtenhorst, M.; Gwinn-Hardy, K.; Paul Murphy, M.; Baker, M.; Yu, X.; Duff, K.; Hardy, J.; Corral, A.; Lin, W. L.; Yen, S. H.; Dickson, D. W.; Davies, P.; Hutton, M. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein Nat. Genet. 2000, 25 (4) 402-5
12. Andorfer, C.; Kress, Y.; Espinoza, M.; de Silva, R.; Tucker, K. L.; Barde, Y. A.; Duff, K.; Davies, P. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms J. Neurochem. 2003, 86 (3) 582-90
13. Hsiao, K.; Chapman, P.; Nilsen, S.; Eckman, C.; Harigaya, Y.; Younkin, S.; Yang, F.; Cole, G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 1996, 274 (5284) 99-102
14. Games, D.; Adams, D.; Alessandrini, R.; Barbour, R.; Berthelette, P.; Blackwell, C.; Carr, T.; Clemens, J.; Donaldson, T.; Gillespie, F. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein Nature 1995, 373 (6514) 523-7
15. Schwab, C.; Hosokawa, M.; McGeer, P. L. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease Exp. Neurol. 2004, 188 (1) 52-64
16. Radde, R.; Duma, C.; Goedert, M.; Jucker, M. The value of incomplete mouse models of Alzheimer's disease Eur. J. Nucl. Med. Mol. Imaging 2008, 35 (Suppl 1) S70-4
17. Oddo, S.; Caccamo, A.; Shepherd, J. D.; Murphy, M. P.; Golde, T. E.; Kayed, R.; Metherate, R.; Mattson, M. P.; Akbari, Y.; LaFerla, F. M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron 2003, 39 (3) 409-21
18. Wilcock, D. M.; Lewis, M. R.; Van Nostrand, W. E.; Davis, J.; Previti, M. L.; Gharkholonarehe, N.; Vitek, M. P.; Colton, C. A. Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2 J. Neurosci. 2008, 28 (7) 1537-45
19. Colton, C. A.; Wilcock, D. M.; Wink, D. A.; Davis, J.; Van Nostrand, W. E.; Vitek, M. P. The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP J Alzheimers Dis. 2008, 15 (4) 571-87
20. Geller, D. A.; Billiar, T. R. Molecular biology of nitric oxide synthases Cancer Metastasis Rev. 1998, 17 (1) 7-23
21. Weinberg, J. B.; Misukonis, M. A.; Shami, P. J.; Mason, S. N.; Sauls, D. L.; Dittman, W. A.; Wood, E. R.; Smith, G. K.; McDonald, B.; Bachus, K. E. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages Blood 1995, 86 (3) 1184-95
22. Mestas, J.; Hughes, C. C. Of mice and not men: differences between mouse and human immunology J. Immunol. 2004, 172 (5) 2731-8
23. Colton, C. A.; Vitek, M. P.; Wink, D. A.; Xu, Q.; Cantillana, V.; Previti, M. L.; Van Nostrand, W. E.; Weinberg, J. B.; Dawson, H. NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (34) 12867-72
24. Ridnour, L. A.; Dhanapal, S.; Hoos, M.; Wilson, J.; Lee, J.; Cheng, R. Y.; Brueggemann, E. E.; Hines, H. B.; Wilcock, D. M.; Vitek, M. P.; Wink, D. A.; Colton, C. A. Nitric oxide-mediated regulation of beta-amyloid clearance via alterations of MMP-9/TIMP-1 J Neurochem. 2012, 123 (5) 736-49
25. Sowell, R. A.; Owen, J. B.; Butterfield, D. A. Proteomics in animal models of Alzheimer's and Parkinson's diseases Ageing Res. Rev. 2009, 8 (1) 1-17
26. Sizova, D.; Charbaut, E.; Delalande, F.; Poirier, F.; High, A. A.; Parker, F.; Van Dorsselaer, A.; Duchesne, M.; Diu-Hercend, A. Proteomic analysis of brain tissue from an Alzheimer's disease mouse model by two-dimensional difference gel electrophoresis Neurobiol. Aging 2007, 28 (3) 357-70
27. Shin, S. J.; Lee, S. E.; Boo, J. H.; Kim, M.; Yoon, Y. D.; Kim, S. I.; Mook-Jung, I. Profiling proteins related to amyloid deposited brain of Tg2576 mice Proteomics 2004, 4 (11) 3359-68
28. Shiozaki, A.; Tsuji, T.; Kohno, R.; Kawamata, J.; Uemura, K.; Teraoka, H.; Shimohama, S. Proteome analysis of brain proteins in Alzheimer's disease: subproteomics following sequentially extracted protein preparation J. Alzheimers Dis. 2004, 6 (3) 257-68
29. Di Domenico, F.; Sultana, R.; Barone, E.; Perluigi, M.; Cini, C.; Mancuso, C.; Cai, J.; Pierce, W. M.; Butterfield, D. A. Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects J. Proteomics 2011, 74 (7) 1091-103
30. Robinson, R. A.; Lange, M. B.; Sultana, R.; Galvan, V.; Fombonne, J.; Gorostiza, O.; Zhang, J.; Warrier, G.; Cai, J.; Pierce, W. M.; Bredesen, D. E.; Butterfield, D. A. Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-beta peptide of amyloid precursor protein(Xi) Neuroscience 2011, 177, 207-22
31. Rudrabhatla, P.; Jaffe, H.; Pant, H. C. Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs FASEB J. 2011, 25 (11) 3896-905
32. Ross, G. W.; O'Callaghan, J. P.; Sharp, D. S.; Petrovitch, H.; Miller, D. B.; Abbott, R. D.; Nelson, J.; Launer, L. J.; Foley, D. J.; Burchfiel, C. M.; Hardman, J.; White, L. R. Quantification of regional glial fibrillary acidic protein levels in Alzheimer's disease Acta Neurol. Scand. 2003, 107 (5) 318-23
33. Noppe, M.; Crols, R.; Andries, D.; Lowenthal, A. Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology Clin. Chim. Acta 1986, 155 (2) 143-50
34. Diedrich, J. F.; Minnigan, H.; Carp, R. I.; Whitaker, J. N.; Race, R.; Frey, W., II; Haase, A. T. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes J. Virol. 1991, 65 (9) 4759-68
35. Barger, S. W.; DeWall, K. M.; Liu, L.; Mrak, R. E.; Griffin, W. S. Relationships between expression of apolipoprotein E and beta-amyloid precursor protein are altered in proximity to Alzheimer beta-amyloid plaques: potential explanations from cell culture studies J. Neuropathol. Exp. Neurol. 2008, 67 (8) 773-83
36. Davis, J.; Xu, F.; Deane, R.; Romanov, G.; Previti, M. L.; Zeigler, K.; Zlokovic, B. V.; Van Nostrand, W. E. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor J. Biol. Chem. 2004, 279 (19) 20296-306
37. Richardson, B. M.; Soderblom, E. J.; Thompson, J. W.; Moseley, M. A. Automated, Reproducible, Titania-Based Phosphopeptide Enrichment Strategy for Label-Free Quantitative Phosphoproteomics J. Biomol. Tech. 2013, 24 (1) 8-16
38. Gilar, M.; Olivova, P.; Daly, A. E.; Gebler, J. C. Orthogonality of separation in two-dimensional liquid chromatography Anal. Chem. 2005, 77 (19) 6426-34
39. Dowell, J. A.; Frost, D. C.; Zhang, J.; Li, L. Comparison of two-dimensional fractionation techniques for shotgun proteomics Anal. Chem. 2008, 80 (17) 6715-23
40. Paweletz, C. P.; Wiener, M. C.; Bondarenko, A. Y.; Yates, N. A.; Song, Q.; Liaw, A.; Lee, A. Y.; Hunt, B. T.; Henle, E. S.; Meng, F.; Sleph, H. F.; Holahan, M.; Sankaranarayanan, S.; Simon, A. J.; Settlage, R. E.; Sachs, J. R.; Shearman, M.; Sachs, A. B.; Cook, J. J.; Hendrickson, R. C. Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry J. Proteome Res. 2010, 9 (3) 1392-401
41. Meng, F.; Wiener, M. C.; Sachs, J. R.; Burns, C.; Verma, P.; Paweletz, C. P.; Mazur, M. T.; Deyanova, E. G.; Yates, N. A.; Hendrickson, R. C. Quantitative analysis of complex peptide mixtures using FTMS and differential mass spectrometry J. Am. Soc. Mass Spectrom. 2007, 18 (2) 226-33
42. Saka, H. A.; Thompson, J. W.; Chen, Y. S.; Kumar, Y.; Dubois, L. G.; Moseley, M. A.; Valdivia, R. H. Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms Mol. Microbiol. 2011, 82 (5) 1185-1203
43. Soderblom, E. J.; Philipp, M.; Thompson, J. W.; Caron, M. G.; Moseley, M. A. Quantitative label-free phosphoproteomics strategy for multifaceted experimental designs Anal. Chem. 2011, 83 (10) 3758-64
44. Reidel, B.; Thompson, J. W.; Farsiu, S.; Moseley, M. A.; Skiba, N. P.; Arshavsky, V. Y. Proteomic profiling of a layered tissue reveals unique glycolytic specializations of photoreceptor cells Mol. Cell. Proteomics 2011, 10 (3) M110 002469
45. Geromanos, S. J.; Vissers, J. P.; Silva, J. C.; Dorschel, C. A.; Li, G. Z.; Gorenstein, M. V.; Bateman, R. H.; Langridge, J. I. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS Proteomics 2009, 9 (6) 1683-95
46. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal. Chem. 2002, 74 (20) 5383-92
47. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry Anal. Chem. 2003, 75 (17) 4646-58
48. Reidel, B.; Thompson, J. W.; Farsiu, S.; Moseley, M. A.; Skiba, N. P.; Arshavsky, V. Y. Proteomic profiling of a layered tissue reveals unique glycolytic specializations of photoreceptor cells Mol. Cell. Proteomics 2011, 10 (3) M110 002469
49. Levin, Y. The role of statistical power analysis in quantitative proteomics Proteomics 2011, 11 (12) 2565-7
50. Cohen, J. Statistical Power Analysis for the Behavioral Sciences, 2 nd ed.; L. Erlbaum Associates: Hillsdale, NJ, 1988; p xxi, 567 p.
51. Soderblom, E. J.; Philipp, M.; Thompson, J. W.; Caron, M. G.; Moseley, M. A. Quantitative label-free phosphoproteomics strategy for multifaceted experimental designs Anal. Chem. 2011, 83 (10) 3758-64
52. Beausoleil, S. A.; Villen, J.; Gerber, S. A.; Rush, J.; Gygi, S. P. A probability-based approach for high-throughput protein phosphorylation analysis and site localization Nat. Biotechnol. 2006, 24 (10) 1285-92
53. Wu, R.; Dephoure, N.; Haas, W.; Huttlin Edward, L.; Zhai, B.; Sowa Mathew, E.; Gygi Steven, P. Correct interpretation of comprehensive phosphorylation dynamics requires normalization by protein expression changes Mol. Cell. Proteomics 2011, 10 (8) M111 009654
54. Silva, J. C.; Gorenstein, M. V.; Li, G.-z.; Vissers, J. P. C.; Geromanos, S. J. Absolute quantification of proteins by LCMS. A virtue of parallel MS acquisition Mol. Cell. Proteomics 2006, 5 (1) 144-156
55. Grossmann, J.; Roschitzki, B.; Panse, C.; Fortes, C.; Barkow-Oesterreicher, S.; Rutishauser, D.; Schlapbach, R. Implementation and evaluation of relative and absolute quantification in shotgun proteomics with label-free methods J. Proteomics 2010, 73 (9) 1740-6
56. Nagele, R. G.; Wegiel, J.; Venkataraman, V.; Imaki, H.; Wang, K. C. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease Neurobiol. Aging 2004, 25 (5) 663-74
57. Rodriguez, J. J.; Olabarria, M.; Chvatal, A.; Verkhratsky, A. Astroglia in dementia and Alzheimer's disease Cell Death Differ. 2009, 16 (3) 378-85
58. Shteynberg, D.; Deutsch, E. W.; Lam, H.; Eng, J. K.; Sun, Z.; Tasman, N.; Mendoza, L.; Moritz, R. L.; Aebersold, R.; Nesvizhskii, A. I. iProphet: multi-level integrative analysis of shotgun proteomic data improves peptide and protein identification rates and error estimates Mol. Cell. Proteomics 2011, 10 (12) M111 007690
59. Carroll, M. V.; Sim, R. B. Complement in health and disease Adv. Drug Deliv. Rev. 2011, 63 (12) 965-75
60. Gawinecka, J.; Dieks, J.; Asif, A. R.; Carimalo, J.; Heinemann, U.; Streich, J. H.; Dihazi, H.; Schulz-Schaeffer, W.; Zerr, I. Codon 129 polymorphism specific cerebrospinal fluid proteome pattern in sporadic Creutzfeldt-Jakob disease and the implication of glycolytic enzymes in prion-induced pathology J. Proteome Res. 2010, 9 (11) 5646-57
61. Gong, Y.; Lippa, C. F.; Zhu, J.; Lin, Q.; Rosso, A. L. Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease Brain Res. 2009, 1292, 191-8
62. Jahn, H.; Wittke, S.; Zurbig, P.; Raedler, T. J.; Arlt, S.; Kellmann, M.; Mullen, W.; Eichenlaub, M.; Mischak, H.; Wiedemann, K. Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers PLoS One 2011, 6 (10) e26540
63. Nagy, J. I.; Li, W.; Hertzberg, E. L.; Marotta, C. A. Elevated connexin43 immunoreactivity at sites of amyloid plaques in Alzheimer's disease Brain Res. 1996, 717 (1-2) 173-8
64. Mei, X.; Ezan, P.; Giaume, C.; Koulakoff, A. Astroglial connexin immunoreactivity is specifically altered at beta-amyloid plaques in beta-amyloid precursor protein/presenilin1 mice Neuroscience 2010, 171 (1) 92-105
65. David, D. C.; Ittner, L. M.; Gehrig, P.; Nergenau, D.; Shepherd, C.; Halliday, G.; Gotz, J. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes Proteomics 2006, 6 (24) 6566-77
66. Solan, J. L.; Marquez-Rosado, L.; Sorgen, P. L.; Thornton, P. J.; Gafken, P. R.; Lampe, P. D. Phosphorylation at S365 is a gatekeeper event that changes the structure of Cx43 and prevents down-regulation by PKC J. Cell Biol. 2007, 179 (6) 1301-9
67. Pannasch, U.; Vargova, L.; Reingruber, J.; Ezan, P.; Holcman, D.; Giaume, C.; Sykova, E.; Rouach, N. Astroglial networks scale synaptic activity and plasticity Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (20) 8467-72
68. McGeer, P. L.; McGeer, E. G. The possible role of complement activation in Alzheimer disease Trends Mol. Med. 2002, 8 (11) 519-23
69. Fonseca, M. I.; Zhou, J.; Botto, M.; Tenner, A. J. Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease J. Neurosci. 2004, 24 (29) 6457-65
70. Benoit, M. E.; Tenner, A. J. Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression J. Neurosci. 2011, 31 (9) 3459-69
71. Fraser, D. A.; Pisalyaput, K.; Tenner, A. J. C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production J. Neurochem. 2010, 112 (3) 733-43
72. Pisalyaput, K.; Tenner, A. J. Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms J. Neurochem. 2008, 104 (3) 696-707
73. Honda, K.; Casadesus, G.; Petersen, R. B.; Perry, G.; Smith, M. A. Oxidative stress and redox-active iron in Alzheimer's disease Ann. N.Y. Acad. Sci. 2004, 1012, 179-82
74. Sultana, R.; Boyd-Kimball, D.; Poon, H. F.; Cai, J.; Pierce, W. M.; Klein, J. B.; Merchant, M.; Markesbery, W. R.; Butterfield, D. A. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD Neurobiol. Aging 2006, 27 (11) 1564-76
75. Belkacemi, A.; Ramassamy, C. Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-beta cascade Free Radic. Biol. Med. 2012, 52 (3) 593-600
76. Huttlin, E. L.; Jedrychowski, M. P.; Elias, J. E.; Goswami, T.; Rad, R.; Beausoleil, S. A.; Villen, J.; Haas, W.; Sowa, M. E.; Gygi, S. P. A tissue-specific atlas of mouse protein phosphorylation and expression Cell 2010, 143 (7) 1174-89
77. Power, J. H.; Asad, S.; Chataway, T. K.; Chegini, F.; Manavis, J.; Temlett, J. A.; Jensen, P. H.; Blumbergs, P. C.; Gai, W. P. Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer's disease pathology Acta Neuropathol. 2008, 115 (6) 611-22
78. Sultana, R.; Boyd-Kimball, D.; Cai, J.; Pierce, W. M.; Klein, J. B.; Merchant, M.; Butterfield, D. A. Proteomics analysis of the Alzheimer's disease hippocampal proteome J. Alzheimers Dis. 2007, 11 (2) 153-64
79. Chen, J. W.; Dodia, C.; Feinstein, S. I.; Jain, M. K.; Fisher, A. B. 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities J. Biol. Chem. 2000, 275 (37) 28421-7
80. Dhawan, L.; Liu, B.; Pytlak, A.; Kulshrestha, S.; Blaxall, B. C.; Taubman, M. B. Y-box binding protein 1 and RNase UK114 mediate monocyte chemoattractant protein 1 mRNA stability in vascular smooth muscle cells Mol. Cell. Biol. 2012, 32 (18) 3768-75
81. Liang, Y.; Van Zant, G. Aging stem cells, latexin, and longevity Exp. Cell Res. 2008, 314 (9) 1962-72
82. Ohama, Y.; Hayashi, K. Relocalization of a microtubule-anchoring protein, ninein, from the centrosome to dendrites during differentiation of mouse neurons Histochem. Cell Biol. 2009, 132 (5) 515-24
83. Wang, X.; Tsai, J. W.; Imai, J. H.; Lian, W. N.; Vallee, R. B.; Shi, S. H. Asymmetric centrosome inheritance maintains neural progenitors in the neocortex Nature 2009, 461 (7266) 947-55
84. Liem, R. K.; Messing, A. Dysfunctions of neuronal and glial intermediate filaments in disease J. Clin. Invest. 2009, 119 (7) 1814-24
85. Lariviere, R. C.; Julien, J. P. Functions of intermediate filaments in neuronal development and disease J. Neurobiol. 2004, 58 (1) 131-48
86. Schoch, S.; Gundelfinger, E. D. Molecular organization of the presynaptic active zone Cell Tissue Res. 2006, 326 (2) 379-91
87. Sudhof, T. C. Calcium control of neurotransmitter release Cold Spring Harbor Perspect. Biol. 2012, 4 (1) a011353
88. Garty, H.; Karlish, S. J. Role of FXYD proteins in ion transport Annu. Rev. Physiol. 2006, 68, 431-59
89. Ohsumi, A.; Nawashiro, H.; Otani, N.; Ooigawa, H.; Toyooka, T.; Shima, K. Temporal and spatial profile of phosphorylated connexin43 after traumatic brain injury in rats J. Neurotrauma 2010, 27 (7) 1255-63
90. Wang, Y.; Song, J. H.; Denisova, J. V.; Park, W. M.; Fontes, J. D.; Belousov, A. B. Neuronal gap junction coupling is regulated by glutamate and plays critical role in cell death during neuronal injury J. Neurosci. 2012, 32 (2) 713-25
91. Iqbal, K.; Liu, F.; Gong, C. X.; Grundke-Iqbal, I. Tau in Alzheimer disease and related tauopathies Curr. Alzheimer Res. 2010, 7 (8) 656-64
92. Trojanowski, J. Q.; Lee, V. M. Phosphorylation of neuronal cytoskeletal proteins in Alzheimer's disease and Lewy body dementias Ann. N.Y. Acad. Sci. 1994, 747, 92-109
93. Kito, K.; Ito, T. Mass spectrometry-based approaches toward absolute quantitative proteomics Curr. Genomics 2008, 9 (4) 263-74
94. Tenner, A. J.; Fonseca, M. I. The double-edged flower: roles of complement protein C1q in neurodegenerative diseases Adv. Exp. Med. Biol. 2006, 586, 153-76
95. Fan, R.; DeFilippis, K.; Van Nostrand, W. E. Induction of complement proteins in a mouse model for cerebral microvascular A beta deposition J. Neuroinflammation 2007, 4, 22
96. Liu, F.; Grundke-Iqbal, I.; Iqbal, K.; Gong, C. X. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation Eur. J. Neurosci. 2005, 22 (8) 1942-50
97. Aidaralieva, N. J.; Kamino, K.; Kimura, R.; Yamamoto, M.; Morihara, T.; Kazui, H.; Hashimoto, R.; Tanaka, T.; Kudo, T.; Kida, T.; Okuda, J.; Uema, T.; Yamagata, H.; Miki, T.; Akatsu, H.; Kosaka, K.; Takeda, M. Dynamin 2 gene is a novel susceptibility gene for late-onset Alzheimer disease in non-APOE-epsilon4 carriers J. Hum. Genet. 2008, 53 (4) 296-302
98. Takano, M.; Maekura, K.; Otani, M.; Sano, K.; Nakamura-Hirota, T.; Tokuyama, S.; Min, K. S.; Tomiyama, T.; Mori, H.; Matsuyama, S. Proteomic analysis of the brain tissues from a transgenic mouse model of amyloid beta oligomers Neurochem. Int. 2012, 61 (3) 347-55
99. Katayama, T.; Imaizumi, K.; Sato, N.; Miyoshi, K.; Kudo, T.; Hitomi, J.; Morihara, T.; Yoneda, T.; Gomi, F.; Mori, Y.; Nakano, Y.; Takeda, J.; Tsuda, T.; Itoyama, Y.; Murayama, O.; Takashima, A.; St. George-Hyslop, P.; Takeda, M.; Tohyama, M. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response Nat. Cell Biol. 1999, 1 (8) 479-85
100. Viana, R. J.; Nunes, A. F.; Rodrigues, C. M. Endoplasmic reticulum enrollment in Alzheimer's disease Mol. Neurobiol. 2012, 46 (2) 522-34
101. Kim, S. H.; Fountoulakis, M.; Cairns, N.; Lubec, G. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome J. Neural Transm. Suppl. 2001, 61, 223-35
102. Polito, L.; Kehoe, P. G.; Davin, A.; Benussi, L.; Ghidoni, R.; Binetti, G.; Quadri, P.; Lucca, U.; Tettamanti, M.; Clerici, F.; Bagnoli, S.; Galimberti, D.; Nacmias, B.; Sorbi, S.; Guaita, A.; Scarpini, E.; Mariani, C.; Forloni, G.; Albani, D. The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts. Alzheimers Dement. 2012.
103. Green, K. N.; Steffan, J. S.; Martinez-Coria, H.; Sun, X.; Schreiber, S. S.; Thompson, L. M.; LaFerla, F. M. Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau J. Neurosci. 2008, 28 (45) 11500-10
104. Tilleman, K.; Stevens, I.; Spittaels, K.; Haute, C. V.; Clerens, S.; Van Den Bergh, G.; Geerts, H.; Van Leuven, F.; Vandesande, F.; Moens, L. Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view Proteomics 2002, 2 (1) 94-104